NCT05354141: An ongoing trial by Direct Biologics, LLC
This trial is ongoing. It must report results 3 months, 2 weeks from now.
Full data
| Full entry on ClinicalTrials.gov | NCT05354141 |
|---|---|
| Title | Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles for Hospitalized Patients With Moderate-to-Severe ARDS: A Phase III Clinical Trial |
| Results Status | Ongoing |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | July 1, 2022 |
| Completion date | March 31, 2025 |
| Required reporting date | March 31, 2026, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | None |